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Abstract We have recently isolated and cloned a novel
endogenous peptide from pig intestine, NK-lysin (NKL). In the
present study we show that NKL (1^100 nM) potently and
reversibly stimulates insulin secretion in rat pancreatic islets and
in the L-cell line HIT T15. This effect of NKL was not
accompanied by changes in cytoplasmic free calcium concentra-
tion. The stimulatory activity of NKL on insulin release was also
observed in permeabilized islets under Ca2+-clamped conditions.
Preincubation of HIT T15 cells with NKL for 1 h or 24 h did not
influence cell viability. Possible mechanisms of insulinotropic
activity of NKL are discussed.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Insulin plays a key role in maintaining blood glucose ho-
meostasis. Increase in glucose concentration leads to secretion
of insulin from the pancreatic L-cell. The molecular mecha-
nisms underlying insulin secretion in the pancreatic L-cell are
not fully understood. Cytoplasmic free calcium concentration
([Ca2]i) plays an important role in insulin secretion [1,2]. The
increase in [Ca2]i results from metabolism of glucose and
thereby an increase in the ATP/ADP ratio with subsequent
closure of ATP-dependent K channels (KATP channels),
membrane depolarization and opening of voltage-dependent
Ca2 channels [1,2]. However, recent data point to the possi-
bility of exocytosis of insulin being promoted without a con-
comitant increase in [Ca2]i, by activation of more distal steps
in the secretory machinery [3^9]. Insulin secretion independent
on concomitant changes in [Ca2]i involves glucose metabo-
lism and is dependent on the activation of protein kinases A
and C [4^8].
Recently we have isolated and cloned a novel endogenous
78 residue basic peptide from pig intestine. This peptide was
named NK-lysin (NKL) and we have shown that it possesses
antimicrobial and antitumor activity in the WM concentration
range [10]. The present study further explores the mode of
action of NKL on mammalian cells. We now show that
NKL potently stimulates insulin secretion in the nM range,
without concomitant changes in [Ca2]i. This means that
NKL belongs to the group of several gut peptides [11,12]
modulating pancreatic L-cell function.
2. Materials and methods
2.1. Materials
NKL was puri¢ed from pig intestine as previously described [10]
and concentrations were based on dry weight of the peptide. Other
chemicals used were from Sigma (USA) and of analytical grade.
2.2. Isolation and incubation of islets of Langerhans
Pancreatic islets were isolated from male Wistar rats (200^250 g) by
collagenase digestion as previously described [13] and maintained
overnight in RPMI 1640 culture medium (Flow Laboratories, Scot-
land, UK), containing 11 mM glucose and supplemented with 10%
(v/v) heat-inactivated fetal calf serum, 2 mM glutamine, 100 Wg/ml
streptomycin and 100 U/ml penicillin.
For measurements of insulin release, islets were preincubated in
Krebs-Ringer bicarbonate bu¡er (KRB) containing (in mM):
115 NaCl, 4.7 KCl, 2.56 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 20 NaHCO3
and 16 HEPES, pH 7.4, supplemented with 1 mg/ml bovine serum
albumin, with 3.3 mM glucose for 30 min at 37‡C. For batch incu-
bation experiments groups of 3 islets were selected and incubated in
300 Wl KRB for 60 min at 37‡C with di¡erent concentrations of NKL
or without the peptide (control). The incubation was terminated by
cooling the samples on ice. Samples were stored at 320‡C until insulin
content was analyzed by radioimmunoassay, using rat insulin (mixture
of the two rat insulins) as a standard (Novo Nordisk, Copenhagen,
Denmark). To measure insulin release in permeabilized islets, islets
were washed three times in a permeabilization bu¡er containing (in
mM): 140 potassium glutamate, 5 NaCl, 1 MgCl2, 10 EGTA,
25 HEPES and 0.25 mg/ml bovine serum albumin. pH was adjusted
to 7.00 with KOH and pCa2 (3log[Ca2]) was adjusted to 7.00 with
CaCl2. Islets were electropermeabilized in this bu¡er by 5 pulses of a
3 kV/cm electric ¢eld, washed and collected in groups of 3 in 300 Wl of
modi¢ed permeabilization bu¡er containing 2 mM ATP and an ATP-
regenerating system consisting of 2 mM creatine phosphate, 10 U/ml
creatine phosphokinase and pCa2 varying from 8 to 5. The actual
pCa2 in the bu¡er was adjusted using a Ca2-selective electrode
(Orion Research, Boston, MA, USA) and solutions with standard
Ca2 concentrations (World Precision Instruments, USA). Islets
were incubated for 15 min at 37‡C and insulin release was measured
by radioimmunoassay.
2.3. Cell culture and study of insulin release from HIT T15 cells
Hamster insulinoma tumor HIT T15 cells were cultured at 37‡C in
RPMI 1640 medium containing 11 mM glucose and supplemented
with 10% (v/v) heat-inactivated fetal calf serum, 2 mM glutamine,
100 Wg/ml streptomycin, 100 U/ml penicillin, 1037 M selenious acid
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and 10 Wg/ml glutathione as previously described [14]. Measurements
of insulin release in HIT T15 cells were performed in medium con-
sisting of (in mM): NaCl 125, KCl 5.9, CaCl2 1.3, MgCl2 1.2 and
HEPES 25, pH 7.4, supplemented with 1 mg/ml bovine serum albu-
min according to the procedure previously described [15].
2.4. Measurements of [Ca2 +]i
[Ca2]i measurements were performed according to the procedure
previously described [4,16] in a medium consisting of (in mM): glu-
cose 3.3, NaCl 125, KCl 5.9, CaCl2 1.3, MgCl2 1.2 and HEPES 25,
pH 7.4, supplemented with 2 mg/ml bovine serum albumin and other
additions as shown in the ¢gure. Single islets were loaded with 2 WM
fura-2/AM for 1 h in a medium containing 3.3 mM glucose. After
loading, the single islet was placed under a microscopic grid in a
custom built open perfusion chamber for microscopic work and main-
tained at 37 þ 0.2‡C. Single islets were perfused at a £ow rate of 0.15
ml/min and measurements of the 340/380 nm £uorescence ratio, re-
£ecting [Ca2]i, were performed.
2.5. Assessment of cell viability
The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) assay was used to assess viability of HIT T15 cells, according
to the procedure previously used for neuronal cells [17]. HIT T15 cells
were incubated with 100 nM or 1 WM NKL in 24-well multiplates for
1 or 24 h. The assay was initiated by removing the old medium and
adding MTT tetrazolium salt dissolved in serum-free culture medium
(0.3 mg/ml, ¢lter-sterilized) for 1 h at 37 C. The medium was then
aspirated and 0.5 ml of isopropanol added. The culture plates were
shaken by hand to ensure that all the MTT formazan crystals were
dissolved and aliquots (100 Wl) of solution were pipetted into 96-well
microplates. The absorbance was recorded at 570 nm with reference at
630 nm in an Anthos htIII microplate reader (Anthos Labtec Instru-
ments, Salzburg, Austria) and the results were expressed as percentage
of intact cells as compared to control untreated cells.
2.6. Data analysis
Data analysis was performed using the programs Sigma Plot for
Windows (version 1.02, Jandel Corp.) and Graph PAD (version 2.0,
Graph PAD software). All results are expressed as means þ S.E.M. for
the indicated number of experiments. Statistical signi¢cance of di¡er-
ences between means was assessed by Student’s t-test for unpaired
data. Di¡erences were considered signi¢cant at P6 0.05.
3. Results
3.1. E¡ect of NKL on insulin secretion
Rat islets showed a dose-dependent release of insulin when
incubated with NKL (Fig. 1A). When islets were incubated at
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Fig. 1. A: Concentration-dependent e¡ect of NKL on insulin release
in rat islets incubated for 30 min at 3.3 mM (open bars) and
16.7 mM (black bars) glucose. Each value represents the mean þ
S.E.M. for four experiments. B: E¡ect of 30 min preincubation of
islets with 100 nM or 1 WM of NKL on their subsequent insulin se-
cretion; open and black bars correspond to 3.3 mM and 16.7 mM
glucose, respectively. *P6 0.05, **P6 0.01, ***P6 0.001, relative to
insulin release in the absence of NKL at a corresponding glucose
concentration.
Fig. 2. Stimulation of insulin release by NKL (100 nM) in electro-
permeabilized rat islets at di¡erent ambient free concentrations of
Ca2. Open and black columns show e¡ects in the absence and in
the presence of NKL, respectively. Each value represents the
mean þ S.E.M. for three experiments. *P6 0.05, **P6 0.01,
***P6 0.001, relative to insulin release in the absence of NKL and
at appropriate Ca2 concentration.
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3.3 mM glucose, a signi¢cant release of insulin was observed
at 1 nM NKL whereas the highest NKL concentration tested,
100 nM, showed a 10-fold increase of insulin release com-
pared to basal levels. In the presence of high glucose (16.7
mM) a signi¢cant stimulation of insulin release could be seen
at 10 nM of NKL, while at 100 nM the stimulatory e¡ect
reached 150%. The e¡ect of NKL on insulin release at high
or low glucose was reversible, since exposure of islets to 100
nM or even to 1 WM NKL followed by washing o¡ the pep-
tide from the medium did not a¡ect subsequent insulin release
either at 3.3 mM or 16.7 mM glucose (Fig. 1B).
The stimulatory e¡ect of NKL on insulin release was also
observed in permeabilized islets under Ca2 -clamped condi-
tions (Fig. 2). At all Ca2 concentrations (1038^1035) 100 nM
NKL increased insulin release by about 100^150%.
In the L-cell line HIT T15, 100 nM NKL stimulated insulin
secretion both in the absence and in the presence of high
glucose (Fig. 3). Insulinotropic e¡ect of the peptide was also
reversible in HIT T15 cells. After preincubation of cells with
100 nM NKL at 0 glucose for 18 h followed by washing o¡
NKL from the medium HIT T15 cells were fully responsive to
a subsequent addition of either 10 mM glucose or 100 nM
NKL, the responses being 98 þ 11 and 126 þ 34% of control
(not preincubated) cells, respectively.
3.2. E¡ect of NKL on [Ca2+]i
Experiments performed on single rat pancreatic islets did
not show any e¡ect of NKL on [Ca2]i in the presence of
either 3.3 or 16.7 mM glucose (Fig. 4).
3.3. NKL e¡ects on cell viability
To assay the e¡ect of NKL on cell viability, HIT T15 cells
were incubated with 100 nM or 1 WM NKL for 1 h or 24 h
and then analyzed for residual living cells using the MTT test.
The results obtained show that preincubation with NKL did
not in£uence the viability of HIT T15 cells (Table 1).
4. Discussion
This study was performed with the aim to search for new
endogenous substances which modulate insulin secretion. It
appears that an endogenous peptide isolated from gut, NK-
lysin, previously shown to possess antimicrobial and antitu-
mor activity, at WM concentrations [10], is a potent stimulator
of insulin secretion in the nM range. The stimulatory e¡ect of
NKL is due to a direct e¡ect of the peptide on the L-cell, since
the insulinotropic e¡ect of the peptide could also be observed
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Fig. 4. E¡ects of NKL on £uorescence ratio F340/F380 corresponding
to [Ca2]i in a single rat pancreatic islet perfused with 3.3 mM glu-
cose (A) or with 16.7 mM glucose (B). Addition of NKL is indi-
cated in the ¢gure. Representative traces out of ¢ve experiments.
Fig. 3. E¡ect of NKL (100 nM) on insulin release in HIT T15 cells
in the absence (open bars) and presence (black bars) of glucose
(10 mM). Each value represents the mean þ S.E.M. for four experi-
ments. *P6 0.05, ***P6 0.001, relative to insulin release in the ab-
sence of NKL at a corresponding glucose concentration.
Table 1
E¡ect of NKL on viability of HIT-T15 cells
1 h incubation (%) 24 h incubation (%)
Control 100 þ 1.3 100 þ 1.6
100 nM NKL 99 þ 1.7 98 þ 1.7
1 WM NKL 100 þ 2.5 97 þ 2.4
Values are expressed as percentage of the untreated control, arbitra-
rily set to 100.
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in the L-cell line HIT T15. NKL stimulated insulin secretion
independent on concomitant changes in [Ca2]i. This was evi-
dent from both experiments showing no increase in [Ca2]i
after addition of NKL and by the observation that NKL
signi¢cantly increased insulin release in permeabilized islets
when Ca2 concentrations were clamped to 1038^1035 M.
NKL belongs to a class of physiologically active peptides
and shares similarities with peptides of the saposin family [18].
It has recently been shown that some peptides of this family
of proteins, e.g. the amoebapores, can damage or even destroy
other cells by pore formation in the plasma membrane of the
target cell [19,20]. However, our data argue against the pos-
sibility that NKL induced increase in insulin release by mak-
ing pores in the plasma membrane of L-cells. First, preincu-
bation with NKL did not a¡ect a subsequent basal or glucose-
stimulated insulin release. Second, if there was any kind of cell
damage by NKL, which made the L-cell plasma membrane
permeable and leaky it should have given rise to in£ux of
extracellular Ca2 and hence to an increase in [Ca2]i. Our
experiments did not reveal any increase in [Ca2]i at either
basal or high glucose. Third, experiments performed on insu-
lin secreting cells with the MTT test showed that NKL (up to
1 WM) did not a¡ect the viability of these cells.
Although NKL appeared not to form pores under our ex-
perimental conditions, it is possible that a membrane activity
of this peptide is responsible for its e¡ect on insulin exocyto-
sis. NKL is an amphiphilc peptide which binds to lipid bi-
layers, destabilizing them [18,21]. The membrane destabilizing
activity of NKL may lead to facilitation of vesicle fusion with
plasma membrane and hence to an increased exocytosis.
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